Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Sep 23, 2023. (Total: 221382Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 11 (of 11 Records)

Query Trace: Thrombosis and BCR[original query]
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis.
Leukemia 2009 May 23 (5): 905-11.
Tefferi A, Pardanani A, Lim K-H, Abdel-Wahab O, Lasho T L, Patel J, Gangat N, Finke C M, Schwager S, Mullally A, Li C-Y, Hanson C A, Mesa R, Bernard O, Delhommeau F, Vainchenker W, Gilliland D G, Levine R
[JAK2V617F mutation in the patients with myeloproliferative disorder and its relation with clinical characteristics].
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2011 Aug 19 (4): 916-20.
Zhu Jun-Fang, Liu Yuan, Liu Pei, Jia Ming-Feng, Cheng Juan, Zhao
JAK2 V617F mutation prevalence in myeloproliferative neoplasms in Pernambuco, Brazil.
Genetic testing and molecular biomarkers 2012 Feb .
Silva RR, Domingues Hatzlhofer BL, Machado CG, Lima AS, Albuquerque DM, Santos MN, Fertrin KY, Costa FF, Araújo AD, Bezerra MA
[Detection and clinical significance of JAK2 V617F mutation in Chinese and Uyghur patients with chronic myeloproliferative in Xinjiang].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2012 Dec 33 (12): 12.
Zhang XY, Maimaitili Y, Li Y, An L, Mao M, Fu L, Baier M, Wang XM
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis.
Leukemia research 2015 May 39 (5): 525-9.
Gianelli Umberto, Iurlo Alessandra, Cattaneo Daniele, Bossi Anna, Cortinovis Ivan, Augello Claudia, Moro Alessia, Savi Federica, Castelli Roberto, Brambilla Cecilia, Bianchi Paola, Primignani Massimo, Cortelezzi Agostino, Bosari Silva
Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Oct .
Krahling Tunde, Balassa Katalin, Kiss Katalin P, Bors Andras, Batai Arpad, Halm Gabriella, Egyed Miklos, Fekete Sandor, Remenyi Peter, Masszi Tamas, Tordai Attila, Andrikovics Hajnal
Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia.
Oncotarget 2016 Jul .
Min-Gu Kang, Hyun-Woo Choi, Jun Hyung Lee, Yong Jun Choi, Hyun-Jung Choi, Jong-Hee Shin, Soon-Pal Suh, Szardenings Michael, Hye-Ran Kim, Myung-Geun Sh
Genetic Polymorphisms of Hemostatic Factors and Thrombotic Risk in Non BCR-ABL Myeloproliferative Neoplasms: A Pilot Study.
Balkan journal of medical genetics : BJMG 2017 Jun 20 (1): 35-42.
Dambrauskien? R, Gerbutavi?ius R, Ugenskien? R, Jankauskait? R, Savukaityt? A, Šimoli?nien? R, Rudžianskien? M, Gerbutavi?ien? R, Juozaityt?
Association of JAK2V617F mutation with thrombosis in Indian patients with Philadelphia negative chronic myeloproliferative neoplasms.
Indian journal of pathology & microbiology 2018 7 61 (3): 371-374.
Singh Kanwaljeet, Sazawal Sudha, Chhikara Sunita, Mahapatra Manoranjan, Saxena Re
Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms.
Neoplasma 2021 10 68 (6): 1341-1350.
Aswad Mohamed Hussam, Kissova Jarmila, Ovesna Petra, Penka Mirosl
Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms.
Open life sciences 2023 2 18 (1): 20220545.
Dambrauskien? R?ta, Gerbutavi?ius Rolandas, Rudžianskien? Milda, Paukštaitien? Renata, Vitkauskien? Astra, Skrodenien? Erika, Remeikien? Diana, Zaborien? Inga, Juozaityt? Elo
TOP